Miltenyi buys Switzerland's Medic Tools
This article was originally published in Clinica
Executive Summary
German biotechnology group Miltenyi Biotech has expanded its sample preparation business with the acquisition of Medic Tools, a Zug, Switzerland-based company specialising in disposable sterile sample homogenisation systems. Miltenyi's MACS technology is considered the gold standard in magnetic cell separation – the cells are then used in various applications including biomedical research and cellular therapy. The addition of Medic Tool's expertise in automated sterile homogenisation of a broad range of sample materials will allow Miltenyi to develop further technologies in the area of sample preparation, said Bergisch Gladbach-based Miltenyi. Financial details of the transaction were not disclosed.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.